<DOC>
	<DOCNO>NCT00167297</DOCNO>
	<brief_summary>The purpose small open-label trial evaluate feasibility recruit cannabis dependent patient treatment Atomoxetine MIT . The clinical data date Atomoxetine limit child adult attention deficit disorder without co-morbid substance dependence . However , one study estimate adult attention deficit disorder rate drug abuse three four time higher control ( Mannuzza S 1998 ) . The study also report cannabis cocaine frequently abuse population .</brief_summary>
	<brief_title>Atomoxetine Treatment Cannabis Dependence</brief_title>
	<detailed_description>This Phase 2 open-label study . We recruit 10 cannabis dependent subject treat combination Atomoxetine MIT reduce consumption cannabis . Subjects 10 men woman current DSM-IV diagnosis cannabis dependence . All patient receive Atomoxetine four session MIT . The study length patient one week baseline screen start medication . This follow 8 week medication end study visit one week complete medication . The PI review information collect regard subject 's eligibility study . The subject return approximately four day later , PI find subject suitable study , subject begin take study medication . This visit refer visit 2 . During visit 2 , PI monitor subject concomitant medication adverse event . The research technician collect Vital Signs , Weight , BAL , TLFB , Urine Tox Screen THC/CR ratio . Both visit 1 2 conduct within first week study . Starting visit 2 , subject take one 25mg capsule Atomoxetine orally seven day . Beginning visit 3 , subject increase dose 40mg per day 3 day , follow 80mg ( two 40mg capsule concurrently ) four day second week . Beginning week 3 , subject take two 40mg capsule ( 80mg total ) every day week 6 week .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Males female , 1865 year old Meets DSMIV criterion Cannabis Dependence Live within commutable distance Treatment Research Center Understands sign inform consent Current DSMIV diagnosis psychoactive substance dependence marijuana , nicotine dependence History learn disability History diagnosis ADHD make psychiatrist . Concomitant treatment psychotropic medication , especially Monoamine Oxidase Inhibitors Mandated treatment base upon legal decision condition employment Current severe psychiatric symptom , e.g . psychosis , dementia , acute suicidal homicidal ideation , mania depression require antidepressant therapy , could make unsafe patient participate opinion primary investigator . Use investigational medication within past 30 day Current treatment pressor agent albuterol . History narrow angle glaucoma . History significant , unstable heart disease , include myocardial infarction , unstable angina , cardiac failure , second third degree heart block , uncontrolled hypertension Known hypersensitivity atomoxetine Subjects know AIDS serious illness , may require hospitalization study Female subject pregnant lactating , female subject child bear potential use acceptable method birth control . Acceptable method birth control include : Barrier ( diaphragm condom ) spermicide Intrauterine device Levonorgestrel implant Medroxyprogesterone acetate contraceptive injection Oral contraceptives Clinical laboratory test ( CBC , blood chemistry , urinalysis ) outside normal limit clinically unacceptable principal investigator . On EKG , 1st degree heart block , sinus tachycardia , leave axis deviation , nonspecific ST T wave change allow . Liver function test ( LFT 's ) &lt; 5 time ULN without symptom liver disease acceptable thorough medical review .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>atomoxetine</keyword>
	<keyword>cannabis dependence</keyword>
	<keyword>treatment</keyword>
</DOC>